Schizophrenia in a patient with subtelomeric duplication of chromosome 22q
about
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia.Investigation of SHANK3 in schizophrenia.SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties.Integrative Analysis of Brain Region-specific Shank3 Interactomes for Understanding the Heterogeneity of Neuronal Pathophysiology Related to SHANK3 Mutations.Striatal Transcriptome and Interactome Analysis of Shank3-overexpressing Mice Reveals the Connectivity between Shank3 and mTORC1 Signaling.SNP array and FISH analysis of a proband with a 22q13.2- 22qter duplication shed light on the molecular origin of the rearrangement.Post-transcriptional regulation of SHANK3 expression by microRNAs related to multiple neuropsychiatric disordersNovel Therapeutic Approach for Autism Spectrum Disorder: Focus on SHANK3Shank Modulates Postsynaptic Wnt Signaling to Regulate Synaptic Development.Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.Shank is a dose-dependent regulator of Cav1 calcium current and CREB target expression.A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis.Neurodevelopmental disease mechanisms, primary cilia, and endosomes converge on the BLOC-1 and BORC complexes.The importance of systematic genetic approach to familial schizophrenia cases and discussion of cryptic mosaic X chromosome aneuploidies in schizophrenia pathogenesis.nArgBP2-SAPAP-SHANK, the core postsynaptic triad associated with psychiatric disorders.Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.Integrative Brain Transcriptome Analysis Reveals Region-Specific and Broad Molecular Changes in -Overexpressing Mice
P2860
Q24621518-65895A10-A694-47FB-8116-E8521CB728CFQ30313279-DB6964E4-5EEF-4A7A-9517-5FC187BB50CFQ30438816-962B3D2C-10E5-47A7-B907-F08835CD4773Q33575832-DDFB4255-BC26-46B3-8360-9569A6054A4EQ33843180-2AE941DB-BEE1-4FFE-ACFE-650CA6FCD793Q35684588-F54C4C4F-4D36-4E98-A267-931DFD5BD750Q36286987-90571267-604F-4E9D-8C32-8BD102EF2A73Q36594944-5ED49282-2403-48AA-9814-A345209A809DQ36932899-6D5E64A7-D6D2-46D5-98E7-1DFCC1931EA1Q38583174-4C9B87F4-D54C-497D-848A-621D4F5D0E2DQ41785202-2D3E1650-11A6-4EE4-96E1-4C16C31F6EEAQ44388729-C1059358-8027-453B-83CA-E7DF7CFCF3F7Q45976861-5B69D030-6794-4B50-AF9D-E540F6DD1C58Q51665731-3927C672-79FD-4B81-A299-BFC5EFCB6D93Q52328704-156B4A07-CD5A-418E-8E46-E83845605E0CQ55453560-80061AB6-A811-4314-8B81-829F492F2EA5Q57752443-E36AB99A-EB1B-43D2-9534-091D0899504F
P2860
Schizophrenia in a patient with subtelomeric duplication of chromosome 22q
description
im Mai 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2007
@uk
name
Schizophrenia in a patient with subtelomeric duplication of chromosome 22q
@en
Schizophrenia in a patient with subtelomeric duplication of chromosome 22q
@nl
type
label
Schizophrenia in a patient with subtelomeric duplication of chromosome 22q
@en
Schizophrenia in a patient with subtelomeric duplication of chromosome 22q
@nl
prefLabel
Schizophrenia in a patient with subtelomeric duplication of chromosome 22q
@en
Schizophrenia in a patient with subtelomeric duplication of chromosome 22q
@nl
P2093
P50
P1433
P1476
Schizophrenia in a patient with subtelomeric duplication of chromosome 22q
@en
P2093
P304
P356
10.1111/J.1399-0004.2007.00819.X
P577
2007-05-10T00:00:00Z